Dhanvantri Jeevan Rekha Adjusts Evaluation Score Amidst Mixed Financial Performance

Dhanvantri Jeevan Rekha, a microcap player in the healthcare services industry, has recently undergone an adjustment in its evaluation score. This revision reflects a shift in technical trends, moving from a mildly bullish stance to a bullish outlook.
The stock's current price stands at 22.75, showing a notable increase from the previous close of 21.70. Over the past year, Dhanvantri Jeevan Rekha has experienced a return of -4.37%, while its profits have seen a rise of 13%. The company's return on equity (ROE) is reported at 4.2, indicating a valuation that is considered very attractive, particularly when compared to its peers' historical averages.

Despite the recent adjustments, the company has shown flat financial performance in the latest quarter, Q1 FY25-26. Long-term growth metrics reveal that net sales have grown at an annual rate of 8.83%, and operating profit has increased by 15.32% over the past five years. However, the company's ability to manage debt appears weak, as indicated by a poor EBIT to interest ratio of -0.16.

For more insights on Dhanvantri Jeevan Rekha's financial trends, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.